Walleye Trading
SGMO

Walleye Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Walleye Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-200
Closed -$1K – 5607
2022
Q1 		$1K Sell
200
-56,400
-100% -$335K ﹤0.01% 5231
2021
Q4 		$425K Sell
56,600
-34,800
-38% -$302K ﹤0.01% 3115
2021
Q3 		$824K Sell
91,400
-6,900
-7% -$68.2K ﹤0.01% 2419
2021
Q2 		$1.18M Buy
98,300
+95,900
+3,996% +$1.09M ﹤0.01% 1972
2021
Q1 		$30K Buy
2,400
+500
+26% +$6.74K ﹤0.01% 4463
2020
Q4 		$30K Buy
+1,900
New +$22.3K ﹤0.01% 4314
2019
Q3 		– Sell
-9,200
Closed -$99K – 4386
2019
Q2 		$99K Sell
9,200
-2,100
-19% -$22.3K ﹤0.01% 3311
2019
Q1 		$108K Buy
+11,300
New +$115K ﹤0.01% 3425
2018
Q4 		– Sell
-8,000
Closed -$136K – 5236
2018
Q3 		$136K Buy
+8,000
New +$122K ﹤0.01% 4028
2018
Q2 		– Sell
-7,900
Closed -$150K – 4863
2018
Q1 		$150K Buy
+7,900
New +$169K ﹤0.01% 3697

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Trading's SGMO Position: Q2 2022 in Review

Walleye Trading sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 9,715 shares — an estimated $56K sold.

Walleye Trading first reported a position in SGMO in Q1 2018 and held it in 3 quarters. The position peaked at $281K in Q4 2020. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.

  • Walleye Trading reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 9,715 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $56K.
  • Walleye Trading first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 3 quarters.
  • Walleye Trading's SANGAMO THERAPEUTICS INC position peaked at $281K in Q4 2020.
  • 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.